171 related articles for article (PubMed ID: 33930475)
21. Detection of metallo-β-lactamase genes in clinically isolated Klebsiella pneumoniae and Klebsiella oxytoca.
Tateno H; Yasuhara T; Sugano E; Tahara S; Ugajin K; Fukuchi K
Rinsho Byori; 2014 Dec; 62(12):1191-6. PubMed ID: 25823233
[TBL] [Abstract][Full Text] [Related]
22. Hypervirulent Klebsiella pneumoniae serotype K1 clinical isolates form robust biofilms at the air-liquid interface.
Cubero M; Marti S; Domínguez MÁ; González-Díaz A; Berbel D; Ardanuy C
PLoS One; 2019; 14(9):e0222628. PubMed ID: 31532800
[TBL] [Abstract][Full Text] [Related]
23. Weak biofilm formation among carbapenem-resistant Klebsiella pneumoniae.
Cusumano JA; Caffrey AR; Daffinee KE; Luther MK; Lopes V; LaPlante KL
Diagn Microbiol Infect Dis; 2019 Dec; 95(4):114877. PubMed ID: 31484626
[TBL] [Abstract][Full Text] [Related]
24. Biofilm inhibitory effect of chlorhexidine conjugated gold nanoparticles against Klebsiella pneumoniae.
Ahmed A; Khan AK; Anwar A; Ali SA; Shah MR
Microb Pathog; 2016 Sep; 98():50-6. PubMed ID: 27321770
[TBL] [Abstract][Full Text] [Related]
25. A survey of beta-lactamases from 618 isolates of Klebsiella spp.
Reig R; Roy C; Hermida M; Teruel D; Coira A
J Antimicrob Chemother; 1993 Jan; 31(1):29-35. PubMed ID: 8444672
[TBL] [Abstract][Full Text] [Related]
26. The Inhibitory Effects of Lactobacillus Supernatants and Their Metabolites on the Growth and Biofilm Formation of Klebsiella pneumoniae.
Kheiri F; Kermanshahi RK; Feizabadi MM
Infect Disord Drug Targets; 2020; 20(6):902-912. PubMed ID: 31903886
[TBL] [Abstract][Full Text] [Related]
27. Serum resistance properties of Klebsiella pneumoniae and K. oxytoca isolated from different sources.
Podschun R; Teske E; Ullmann U
Zentralbl Hyg Umweltmed; 1991 Nov; 192(3):279-85. PubMed ID: 1777008
[TBL] [Abstract][Full Text] [Related]
28. [Investigation of the correlation between biofilm forming ability of urinary Candida isolates with the use of urinary catheters and change of antifungal susceptibility in the presence of biofilm].
Aslan H; Gülmez D
Mikrobiyol Bul; 2016 Apr; 50(2):256-65. PubMed ID: 27175498
[TBL] [Abstract][Full Text] [Related]
29. Expression of adhesin genes and biofilm formation among Klebsiella oxytoca clinical isolates from patients with antibiotic-associated haemorrhagic colitis.
Ghasemian A; Mohabati Mobarez A; Najar Peerayeh S; Talebi Bezmin Abadi A; Khodaparast S; Mahmood SS
J Med Microbiol; 2019 Jul; 68(7):978-985. PubMed ID: 31136296
[TBL] [Abstract][Full Text] [Related]
30. Biofilm Formation and Virulence Determinants of Klebsiella oxytoca Clinical Isolates from Patients with Colorectal Cancer.
Abbas AF; Al-Saadi AGM; Alkhudhairy MK
J Gastrointest Cancer; 2020 Sep; 51(3):855-860. PubMed ID: 31659674
[TBL] [Abstract][Full Text] [Related]
31. Discrimination of Klebsiella pneumoniae and Klebsiella oxytoca phylogenetic groups and other Klebsiella species by use of amplified fragment length polymorphism.
Jonas D; Spitzmüller B; Daschner FD; Verhoef J; Brisse S
Res Microbiol; 2004; 155(1):17-23. PubMed ID: 14759704
[TBL] [Abstract][Full Text] [Related]
32. [Hydrolytic and haemolytic activity of Klebsiella pneumoniae and Klebsiella oxytoca].
Sekowska A; Gospodarek E; Janickca G; Jachna-Sawicka K; Sawicki M
Med Dosw Mikrobiol; 2006; 58(2):135-41. PubMed ID: 17133907
[TBL] [Abstract][Full Text] [Related]
33. The Toxin-Producing Pathobiont Klebsiella oxytoca Is Not Associated with Flares of Inflammatory Bowel Diseases.
Zollner-Schwetz I; Herzog KA; Feierl G; Leitner E; Schneditz G; Sprenger H; Prattes J; Petritsch W; Wenzl H; Kump P; Gorkiewicz G; Zechner E; Högenauer C
Dig Dis Sci; 2015 Nov; 60(11):3393-8. PubMed ID: 26091802
[TBL] [Abstract][Full Text] [Related]
34. Use of automated repetitive-sequence-based PCR for rapid laboratory confirmation of nosocomial outbreaks.
Grisold AJ; Zarfel G; Strenger V; Feierl G; Leitner E; Masoud L; Hoenigl M; Raggam RB; Dosch V; Marth E
J Infect; 2010 Jan; 60(1):44-51. PubMed ID: 19879293
[TBL] [Abstract][Full Text] [Related]
35. Emergence of ArmA, a 16S rRNA methylase in highly aminoglycoside-resistant clinical isolates of Klebsiella pneumoniae and Klebsiella oxytoca in Okinawa, Japan.
Uechi K; Tada T; Shimada K; Nakasone I; Sonozaki T; Kirikae T; Fujita J
J Infect Chemother; 2018 Jan; 24(1):68-70. PubMed ID: 29066218
[TBL] [Abstract][Full Text] [Related]
36. Biofilm formation of panresistant
Tuncer G; Aktas Z; Basaran S; Cagatay A; Eraksoy H
Future Microbiol; 2022 Jul; 17():723-735. PubMed ID: 35443798
[No Abstract] [Full Text] [Related]
37. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
Moland ES; Sanders CC; Thomson KS
J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
[TBL] [Abstract][Full Text] [Related]
38. Nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Klebsiella oxytoca in Austria.
Hoenigl M; Valentin T; Zarfel G; Wuerstl B; Leitner E; Salzer HJ; Posch J; Krause R; Grisold AJ
Antimicrob Agents Chemother; 2012 Apr; 56(4):2158-61. PubMed ID: 22290949
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the influence of culturing on the intensity of biofilm formation by Klebsiella pneumoniae strains.].
Ignatova NI; Alexandrova NA; Zaslavskaya MI; Abramycheva DV
Klin Lab Diagn; 2020 Jul; 65(8):512-515. PubMed ID: 32762195
[TBL] [Abstract][Full Text] [Related]
40. Difference in biofilm formation between carbapenem-resistant and carbapenem-sensitive Klebsiella pneumoniae based on analysis of mrkH distribution.
Fang R; Liu H; Zhang X; Dong G; Li J; Tian X; Wu Z; Zhou J; Cao J; Zhou T
Microb Pathog; 2021 Mar; 152():104743. PubMed ID: 33484812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
